In December 2019, an outbreak associated with a novel, highly contagious coronavirus emerged in Wuhan, Hubei Province, China. It was subsequently labeled as coronavirus disease 2019 (COVID-19) (
1). The virus spread created a pandemic, with a mean mortality rate of 3.4% calculated based on the data of 135 nations (
2). The current COVID-19 pandemic compares to other pandemics, such as the 2003 severe acute respiratory syndrom (SARS) epidemic and the 2009 H1N1 pandemic. These earlier viruses were similar in transmissibility, hospitalization, severe acute respiratory distress, and mortality (
3-
5). Different countries around the globe applied restrictions, such as social distancing and lockdown (
6), which could cause additional stress (
7).
Public and public health officials, clinicians, and researchers have been highly concerned about the mortality rate and effect of the virus on patients with chronic diseases (
8). In addition to physical well-being, the COVID-19 pandemic affects behavioral and mental health (
9). Restrictions make people feel isolated, lonely, stressed, anxious, and helpless. Individuals may have deep concerns about being in contact with someone who has COVID-19 (
2,
10). Moreover, becoming ill or dying (
11,
12) and losing a loved one results in stress due to grief and bereavement (
13).
It has been observed that stress related to Covid has become widespread during the pandemic (
14,
15). High levels of stress during pandemics can predict negative behaviors and psychological problems, such as panic buying and anxiety over mild non-COVID symptoms (
16-
18). More realistically, low to moderate COVID stress levels may positively influence social and protective behaviors that may lower the infection rate (
7,
19). There have been few validated COVID-related stress measures. Ahorsu et al. (
10) recently developed the "Fear of COVID-19 Scale" in Iran. However, we are unaware of validity and reliability of this measure. Therefore, this study aimed to develop and initially assess the validity and reliability of a new scale, the COVID-19 Stress Scale (CSS), using data from the Iranian non-clinical population.
COVID-19 and its consequences have caused stress and psychological injuries (
15). Stressful conditions, such as epidemics, can increase stress even in healthy people. Improving symptoms in people with mental disorders can lead to various psychological consequences (
20). In addition to benefits, such as survival and motivation, stress has potentially detrimental effects and can negatively impact various dimensions, including sleep, learning, endocrine system, cardiovascular health, digestion, and memory (
21). COVID-19-related stress is caused by various factors, such as dangerous and contagious diseases, unpredictable conditions, and uncertainty about treatment (
22). Furthermore, fear of spreading the disease to others, as well as the social and economic consequences of COVID-19, are other factors that influence the stress caused by this disease. A study conducted in 18 countries in North Africa and the Middle East showed that more than half of the participants experienced the stress of COVID-19 because of domestic issues, and more than one-third of participants experienced COVID-19 stress related to work and financial issues (
23). Moreover, the decrease in sports activities in almost half of the participants due to the quarantine of the epidemic was another negative impact of COVID-19 stress. COVID stress and its consequences, including quarantine, social distancing, and financial problems, led to a decline in school and social activities and even changes in eating habits and lifestyle. This stress has also resulted in diminished physical activity, weight gain, and an increased risk of heart disease (
24). COVID-19 stress causes people to feel guilty because they worry about getting sick. The death of relatives and the inability to cope with stress leads people to resort to unscientific and unreliable medications and methods. This is harmful to them and worsens the situation (
22). Therefore, to provide a suitable platform for research, assessment, and evaluation, it is necessary to develop scales to study the effects of this condition (
17).
Information about this epidemic can be more accurately measured, assessed, and evaluated with reliable tools, and appropriate decisions can be made in various areas based on this information and accurate measurements. For this purpose, a valid, accurate, and appropriate psychometric instrument is needed. Considering that Iran is one of the countries with the highest rates of COVID-19 prevalence and death, we attempted to establish a valid CSS.